Real-world smartphone keyboard interactions discriminates between different levels of disability in multiple sclerosis

被引：0
|
作者：
Lam, K.
Hoeijmakers, A.
Licitra, G.
Meijer, K.
Killestein, J.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-114
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [31] Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register
    Lepore, V
    Bosetti, C.
    Santucci, C.
    Iaffaldano, P.
    Trojano, M.
    Mosconi, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (02) : 567 - 578
  • [32] Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program
    Wiendl, Heinz
    Spelman, Tim
    Butzkueven, Helmut
    Kappos, Ludwig
    Trojan, Maria
    Su, Ray
    Campbell, Nolan
    Ho, Pei-Ran
    Licata, Stephanie
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (05) : 719 - 728
  • [33] Cognitive Function at Different Levels of Neurologic Disability in Veterans with Multiple Sclerosis
    Dux, M. C.
    Lee-Wilk, T.
    Tyner, C.
    Culpepper, W. J.
    Wallin, M.
    Bever, C. T.
    Royal, W., III
    CLINICAL NEUROPSYCHOLOGIST, 2015, 29 (03) : 355 - 355
  • [34] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [35] Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
    Norborg, H.
    Riise, T.
    Myhr, K. -M.
    Grytten, N.
    Wergeland, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 712 - 712
  • [36] Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population
    Coban, Hamza
    Germaine, Sarah
    Dimaandal, Ian
    Haberli, Nicholas
    Padam, Charanpreet
    Creed, Marina A.
    Imitola, Jaime
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
  • [37] Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
    Norborg, Hilde
    Riise, Trond
    Myhr, Kjell-Morten
    Grytten, Nina
    Wergeland, Stig
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [38] Real-world walking in multiple sclerosis: Separating capacity from behavior
    Engelhard, Matthew M.
    Patek, Stephen D.
    Lach, John C.
    Goldman, Myla D.
    GAIT & POSTURE, 2018, 59 : 211 - 216
  • [39] Real-World Fingolimod efficacy and safety in Emirati patients with multiple sclerosis
    Ceccarelli, Antonia
    Mifsud, Victoria
    Elhennawy, Rawan Yasser Gaber
    Benedetti, Beatrice
    Hussain, Syed
    Samples, Stephen
    NEUROLOGY, 2019, 92 (15)
  • [40] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
12345